Get the Facts About Patient Driving Safety & Opioid Treatment

Health professionals caring for patients who receive opioid agonist treatment (OAT) need to be aware of the potential impact of treatments and other factors on driving safety.

The University of Sydney, NSW Ministry of Health and NSW Users & AIDS Association have collaborated to develop the Driving Safety: Sedating Medications and Opioid Agonist Treatment course.

This 30-minute online training module is designed to support health professionals in assessing a patient’s fitness to drive, with a focus on sedating medications and OAT. You can enrol online at anytime, and will receive a certificate upon completion.

By completing this short course, you will meet the following learning objectives:

  • Identify factors that can impact on driving safety and diagnosing risks to driving for patients, including those receiving opioid agonist treatment (OAT).
  • Develop an understanding of short-term fitness to drive and long-term medical fitness to drive, including key assessment considerations.
  • Incorporate knowledge around roles and responsibilities, patient confidentiality, and difficult clinical conversations to effectively manage patients in the context of fitness to drive.
  • Understand the medical standards for licensing and reporting legislation within New South Wales.

CPD is available for members of the RACGP and ACRRM. Simply supply your member number at registration.

Visit www.drivingsafety.com.au for more information.